Neurovive (NEVPF) 2.3300 $NEVPF Neurovive

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Neurovive (NEVPF) 2.3300 $NEVPF

Neurovive Pharmaceutical: NeuroVive Share Upgraded on OTC Market in US
Business Wire - Fri Jun 26, 10:28AM CDT
Regulatory News:

Neurovive Pharmaceutical: Neurovive Reports Topline Results of Phase III CIRCUS Study in Acute Myocardial Infarction
Business Wire - Mon Jun 01, 1:47AM CDT
Regulatory News:

NeuroVive Asia Signs Collaboration Agreement with Sanofi for the Development and Commercialization of Ciclomulsion(R) in South Korea
Business Wire - Tue May 26, 3:30AM CDT
Regulatory News:

Neurovive Pharmaceutical: Topline Result of Phase III Study of Ciclomulsion(R) in Acute Myocardial Infarction Expected This Quarter
Business Wire - Mon May 25, 1:43AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive: Interim report 1 Jan. 2015 till 31 Mar. 2015
Business Wire - Wed May 20, 1:54AM CDT
Regulatory News:

Global Ischemic Stroke Pipeline Report 2015
M2 - Thu May 14, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w6cj3m/ischemic_stroke) has announced the addition of the "Ischemic Stroke - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AB Science - Acorda Therapeutics, Inc. - Acticor Biotech - advanceCor GmbH - AGY Therapeutics, Inc. - Angion Biomedica Corp. - AstraZeneca PLC - Athersys, Inc. - Biogen Idec Inc. - BioTime, Inc. - D-Pharm Ltd. - Daiichi Sankyo Company, Limited - DiaMedica Inc. - Digna Biotech, S.L. - Genervon Biopharmaceuticals, LLC - GlaxoSmithKline plc - International Stem Cell Corporation - Laboratoires Pierre Fabre SA - Lumosa Therapeutics Co., Ltd. - MediaPharma s.r.l. - Mesoblast Limited - Mitsubishi Tanabe Pharma Corporation - Neuralstem, Inc. - Neurotec Pharma SL - NeuroVive Pharmaceutical AB - Panacea Pharmaceuticals, Inc. - Pharmicell Co., Ltd. - PhytoHealth Corporation - SanBio, Inc. - Saneron CCEL Therapeutics, Inc. - Simcere Pharmaceutical Group - Stemedica Cell Technologies, Inc. - Vicore Pharma AB - Virogenomics, Inc. For more information visit http://www.researchandmarkets.com/research/w6...mic_stroke
BIIB: 388.23 (-11.06), ACOR: 34.07 (+0.65), GSK: 42.45 (+0.65), AZN: 66.45 (+1.90), ATHX: 1.14 (-0.01), CUR: 1.69 (-0.01)

NeuroVive Pharmaceutical: NeuroVive Completes Share Issue Raising SEK 70 Million for the Preparation of CicloMulsion(R)'s Clinical Trial in the US and Commercialization in Europe
Business Wire - Fri May 08, 1:33AM CDT
Regulatory News:

NeuroVive Announces the Intention to Raise Additional Capital Through a Private Placement
Business Wire - Thu May 07, 10:50AM CDT
Regulatory News:

Neurovive Pharmaceutical: FIrst Patient Enrolled in Clinical Phase II Study for Kidney Protection During Heart Surgery
Business Wire - Mon Apr 27, 1:47AM CDT
Regulatory News:

Neurovive Pharmaceutical: Clinical Phase II Study with NeuroSTAT(R) for Traumatic Brain Injury Passes Safety Evaluation
Business Wire - Tue Apr 21, 3:06AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive establishes subsidiary in Lyon and extends collaboration with HCL
Business Wire - Mon Apr 20, 1:41AM CDT
Regulatory News:

NeuroVive Pharmaceutical: Development of NVP014 for the Treatment of Stroke Enters New Phase in Collaboration with Isomerase Therapeutics
Business Wire - Fri Apr 17, 1:40AM CDT
Regulatory News:

NeuroVive Pharmaceutical reports change in number of shares and votes
M2 - Wed Apr 01, 3:08AM CDT
NeuroVive Pharmaceutical AB (STO:NVP), the mitochondrial medicine company, announced on Tuesday that the number of shares and votes of the company, registered with the Swedish Companies Registration Office, has increased by 1,300,000.

Week In Review: Cellular Biomedicine In-Licenses Cancer Immunotherapy From China
ChinaBio Today - at Seeking Alpha - Sun Feb 15, 10:14AM CST
Deals and Financings Cellular Biomedicine Group (NASDAQ: CBMG ), a China-US cell therapy company, acquired CAR-T cancer immunotherapy technology from the Chinese PLA General Hospital (the 301 hospital) of Beijing (see story ). The two groups will...
NVO: 57.68 (+2.91), MRK: 57.95 (+0.57), QGEN: 25.73 (+1.00), CBMG: 29.80 (+0.31)

OnCore Biopharma and Tekmira Pharmaceuticals Files for Merger - Releases Further Details about License Agreement With NeuroVive
Business Wire - Thu Feb 05, 2:28AM CST
Regulatory News:
TKMR: 11.71 (+0.46)

Neurovive Pharmaceutical: NeuroVive and Skane University Hospital Initiate Collaboration on Clinical Phase II Study on Kidney Protection During Heart Surgery
Business Wire - Tue Dec 02, 1:40AM CST
Regulatory News:

NeuroVive reduces loss in third quarter 2014
M2 - Thu Nov 20, 4:57AM CST
NeuroVive Pharmaceutical AB (STO:NVP) on Wednesday reported loss before tax of SEK3,761,000, or diluted loss per share of SEK0.18, for the third quarter of 2014, from 1 July 2014 to 30 September 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 4

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading
Navigating Legal Advice Post-Car Crash: A Crucial Guide

Updated Category News Views 0

It's a simple blink-and-you-miss-it moment: one second you're cruising down the street, and the next you're in a fender bender. But if you think you can handle everything solo from here on out, think again. A HelloNation article featuring Pittsburgh attorney Frank Walker brings crucial clarity to when and why you might need a lawyer after a car crash. The Misleading Calm...

Continue Reading
Genimous Lands a Role as an OpenAI Select Partner

Updated Category News Views 4

Genimous Teaming Up with OpenAI Genimous just got the nod from OpenAI, bagging a spot as a Select Partner. Now, if you've been paying any attention, you know OpenAI isn’t handing out partnerships like Halloween candy. Genimous got this shiny badge due to its work in digital interaction marketing. We’re talking from gaming to e-commerce, they’ve got the hands in...

Continue Reading
InfraMed Expands Team for National Healthcare Growth

Updated Category News Views 3

InfraMed's Bold Move in Healthcare Real Estate You know, it’s not every day you see a company go all in on healthcare properties like InfraMed’s doing. With the blitz of new personnel, we're talking about a genuine push to carve out a piece of the national market. And if you've been keeping tabs, this isn't just a hunch—they've got serious momentum brewing, and the...

Continue Reading
FIBRA Prologis Posts Strong Q3 2026 Results Amid Market Trends

Updated Category News Views 5

Decoding FIBRA Prologis' Latest Numbers Never a dull moment in industrial real estate, folks—and FIBRA Prologis (BMV:FIBRAPL 14) just dropped its third quarter earnings results for 2026, lighting a fire in its trajectory. On the surface, their numbers seem to belt out a victory anthem, but let's peel back the layers to understand what truly hums under the hood. A...

Continue Reading
New American Perspectives Shines at HIFF 2026

Updated Category News Views 5

Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....

Continue Reading
Selling Your Home? Key Fixes John Spear Recommends

Updated Category News Views 3

Cracking the Code of Real Estate in Cape Girardeau If you're about to stick that 'For Sale' sign in the lawn, listen up. Cape Girardeau's own real estate legend, John Spear—lovingly dubbed "Mr. Cape Girardeau" for good reason—is spilling the beans on what to spruce up before selling your humble abode. And spoiler alert: it's not about blowing a year's salary on a...

Continue Reading
Anrok Integrates AI for Seamless Tax Management Efficiency

Updated Category News Views 5

Streamlining Tax Management with AI Integration You know, managing tax data can be as thrilling as watching paint dry, but Anrok's latest move might just shake the dullness out of it. San Francisco's own Anrok has rolled out their Anrok MCP, a game-changer that's putting tax management into the fast lane. This isn't just about tossing out the old tax data headaches, it's...

Continue Reading
ESENTIA Sets Stage for Q3 2026 Earnings Insights

Updated Category News Views 4

A Snapshot of What's Coming You know the drill, folks—when the calendar flips close to earnings season, the scramble starts for details that make or break the quarter. ESENTIA Energy Development, the big dog in the Mexican natural gas scene, is poised to drop its third-quarter 2026 numbers right after the market bell sounds on October 28th. They've been flexing their...

Continue Reading
SportsMed Expands with Hoboken Clinic Opening

Updated Category News Views 6

SportsMed's Strategic Hoboken Leap The healthcare landscape in New Jersey and Connecticut's about to get a shake-up, and all eyes should be on SportsMed Physical Therapy. They've just planted their flag in Hoboken with a new clinic, bumping their operational presence up to a whopping 57 clinics. Quite the comeback story from their humble beginnings. Now, that's some...

Continue Reading

Top 5 Most Recently Viewed Articles

La Verde Strikes Big with New Copper-Gold Finds

Updated Category News Views 13

La Verde's Impressive Drill Results: A Deeper Dive When the earth gives up treasures richer than predicted, you know you've struck something special. La Verde, the emerging copper-gold sensation south of Costa Fuego, just did exactly that. Hot Chili Limited's recent diamond drill hole (DKD044) coughed up 391.1 meters grading at 0.51% copper equivalent (CuEq) straight from...

Continue Reading
Critical Metals Corp's Strategic Move with REalloys Inc. Partnership

Updated Category News Views 158

Critical Metals Corp Forms Strategic Pact with REalloys Inc. Critical Metals Corp (NASDAQ: CRML) has taken an important step in fortifying its position in the rare earths market by announcing a new off-take agreement with REalloys Inc. This partnership will see Critical Metals deliver up to 15% of its production from the Tanbreez Project, a significant development for...

Continue Reading
Empowering Families Through Mesothelioma Awareness Series

Updated Category News Views 164

Meso: The Mesothelioma Podcast Offers Vital Support Mesothelioma represents more than just a medical term; it is a profound challenge that can dramatically affect the lives of those diagnosed, along with their families and caregivers. In light of this, a new initiative has emerged aimed at lighting the path towards better understanding and coping mechanisms for those...

Continue Reading
Emeren Group Completes Sale of Renewable Energy Portfolio

Updated Category News Views 151

Emeren Group Completes Remarkable Sale of Solar Portfolio Emeren Group Ltd, known for its expertise in solar energy, has recently completed the sale of a notable 17 MW operational solar portfolio. This project, consisting of a solid 15 MW under a Power Purchase Agreement (PPA) and an additional 2 MW, was fully developed and constructed by the skilled team at Emeren. The...

Continue Reading
Understanding Market Dynamics Behind Boston Scientific's Options

Updated Category News Views 197

Boston Scientific's Market Overview Recent observations from key financial analysts indicate significant bearish activities surrounding Boston Scientific. Understanding the behavior of these market giants is crucial for investors. Our detailed analysis of Boston Scientific (NYSE: BSX) options activity shows notable patterns that investors should consider. Key Trading...

Continue Reading